H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 413,066. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Tulsa clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Tulsa storefront.
Growth Factor Therapy for Tissue Repair in Tulsa, OK for clinics & physicians. Growth factor therapy produ… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Tulsa is JH (Novitas Solutions) and that adult diabetes here is 12.8% (PLACES 2023), it is selling units, not a program. That is the growth factor therapy conversation we actually have.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)14.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 413,066 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult arthritis here is 25.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Tulsa.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 25.1%. That is place-level BRFSS modeling, not a clinic census and not a Tulsa trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Tulsa as local reviews.
Oklahoma is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Bring specialty, monthly joint / regenerative volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.8% diabetes and 25.1% arthritis for Tulsa — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Tulsa, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Tulsa is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Tulsa — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Tulsa. Useful for joint-program math; still needs a diagnosis and privileging.
No Tulsa storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.